D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4201
DELISTED
Reservoir Media Inc Warrant
RSVRW
| $82.2K | ﹤0.01% |
547,924
| – | – |
2022 Q3
14 quarters
|
|
4202
EQV Ventures Acquisition Corp II Warrants
EVAC.WS
| $81.6K | ﹤0.01% |
272,133
| – | – |
2025 Q3
2 quarters
|
|
4203
Aligos Therapeutics
ALGS
$34.4M
| $81.6K | ﹤0.01% |
+10,978
| New | +$83.3K |
2026 Q1
0 quarters
|
|
4204
OneIM Acquisition Corp Warrant
OIMAW
$2.94M
| $81.3K | ﹤0.01% |
+125,000
| New | +$90.4K |
2026 Q1
0 quarters
|
|
4205
SITE Centers
SITC
$161M
| $80.3K | ﹤0.01% |
+14,864
| New | +$91.1K |
2026 Q1
0 quarters
|
|
|
UHGWW
4206
DELISTED
United Homes Group Warrant
UHGWW
| $80.3K | ﹤0.01% |
439,789
| – | – |
2021 Q2
19 quarters
|
|
4207
Drugs Made In America Acquisition II Corp Right
DMIIR
| $80K | ﹤0.01% |
1,000,000
| – | – |
2025 Q4
1 quarter
|
|
4208
PUT
Algoma Steel
ASTL
$453M
| $79.3K | ﹤0.01% |
19,200
| – | – |
2025 Q4
1 quarter
|
|
|
CCIXW
4209
DELISTED
Churchill Capital Corp IX Warrant
CCIXW
| $78.8K | ﹤0.01% |
175,000
| – | – |
2024 Q3
6 quarters
|
|
4210
X3 Acquisition Corp Warrant
XCBEW
| $78.1K | ﹤0.01% |
+325,000
| New | +$85.7K |
2026 Q1
0 quarters
|
|
4211
AH Realty Trust
AHRT
$451M
| $77.3K | ﹤0.01% |
+14,051
| New | +$89.7K |
2026 Q1
0 quarters
|
|
4212
PLAYSTUDIOS Inc
MYPS
$46.7M
| $76.7K | ﹤0.01% |
16,356
| – | – |
2023 Q4
9 quarters
|
|
4213
Aquestive Therapeutics
AQST
$586M
| $75.3K | ﹤0.01% |
18,149
-923,048
| -98% | -$3.75M |
2024 Q1
8 quarters
|
|
4214
NioCorp Developments Ltd Warrant
NIOBW
$24.5M
| $72.5K | ﹤0.01% |
44,211
| – | – |
2023 Q1
12 quarters
|
|
4215
SilverBox Corp V Warrants
SBXE.WS
| $70.7K | ﹤0.01% |
+166,666
| New | +$57.4K |
2026 Q1
0 quarters
|
|
4216
Vine Hill Capital Investment Corp II Warrants
VHCPW
$2.53M
| $69.7K | ﹤0.01% |
+183,333
| New | +$69K |
2026 Q1
0 quarters
|
|
|
LEGT.WS
4217
DELISTED
Legato Merger Corp III Warrants
LEGT.WS
| $68K | ﹤0.01% |
136,100
| – | – |
2024 Q2
7 quarters
|
|
|
RAAQW
4218
DELISTED
Real Asset Acquisition Corp Warrants
RAAQW
| $66.3K | ﹤0.01% |
50,000
| – | – |
2025 Q2
3 quarters
|
|
4219
Republic Digital Acquisition Co Warrants
RDAGW
$3.3M
| $66K | ﹤0.01% |
150,000
| – | – |
2025 Q2
3 quarters
|
|
4220
Pantages Capital Acquisition Corp Right
PGACR
| $65K | ﹤0.01% |
325,000
| – | – |
2025 Q1
4 quarters
|
|
4221
Enovix
ENVX
$551M
| $64.5K | ﹤0.01% |
12,457
-91,682
| -88% | -$574K |
2025 Q2
3 quarters
|
|
4222
CALL
Webull Corp
BULL
$3.41B
| $60K | ﹤0.01% |
+12,500
| New | +$81K |
2026 Q1
0 quarters
|
|
4223
Safeguard Acquisition Corp Warrants
SAC.WS
| $60K | ﹤0.01% |
+150,000
| New | +$69.1K |
2026 Q1
0 quarters
|
|
4224
Octave Specialty Group
OSG
$214M
| $59.8K | ﹤0.01% |
12,864
-31,262
| -71% | -$179K |
2020 Q4
21 quarters
|
|
4225
Richtech Robotics
RR
$331M
| $58.9K | ﹤0.01% |
+28,168
| New | +$86.6K |
2026 Q1
0 quarters
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.